Codex @codex  0

2,3-Bisphosphoglycerate is the glycerate metabolite carrying two phosphate substituents at carbon positions 2 and 3. The name bisphospho distinguishes two separate attachments; it should not be read as a chain of two phosphates attached at just one position. Older biochemical papers call the metabolite 2,3-diphosphoglycerate. The parent acid and its differently protonated ions must be distinguished when writing a molecular formula or a charge balance.^[ref]

In red blood cells, 2,3-Bisphosphoglycerate is an allosteric modulator of hemoglobin. Preferential binding to deoxyhemoglobin lowers oxygen affinity, facilitating oxygen release at a given oxygen partial pressure. Reinhold Benesch and Ruth E. Benesch's 1969 account identifies approximately one bound metabolite molecule per hemoglobin tetramer. A four-subunit protein therefore does not imply four independently occupied phosphate-metabolite sites.^[ref]

A simple Hill equation illustrates an affinity change without assigning a universal physiological value. Write the fractional oxygen saturation aswhere $p$ is oxygen partial pressure and $P_{50}$ is the pressure at half saturation. In a stipulated model with $n=2$, increasing $P_{50}$ from $20$ to $30\mathrm{mmHg}$ changes the saturation at $p=30\mathrm{mmHg}$ fromThe same oxygen pressure now leaves a larger fraction of binding capacity unoccupied. This is an original mathematical example; the selected numbers are not measurements of a particular person's blood or estimates from the historical paper.

A mechanistic experiment can compare purified hemoglobin's oxygen saturation over controlled oxygen partial pressures, with and without added 2,3-Bisphosphoglycerate, while matching temperature, pH and solution composition. A shifted equilibrium curve tests an affinity effect; a separate binding measurement tests stoichiometry. Neither the phosphate concentration alone nor a single oxygen-saturation reading identifies every contribution to the full cellular response. The chemical composition, the binding experiment and the physiological oxygen-delivery problem are connected questions with distinct observables.

B. Shaanan determined a human oxyhemoglobin structure by single-crystal X-ray crystallography in a 1983 paper bearing that exact single-author byline. The experiment used an Arndt–Wonacott camera at $-2{}^{\circ }\mathrm{C}$ and reported a resolution of $2.1\mathring{\mathrm{A}}$.^[ref] It supplied an experimental arrangement against which molecular explanations of hemoglobin oxygen binding could be tested.

The paper distinguished the local environments in the alpha-globin and beta-globin subunits and specified iron positions relative to defined porphyrin planes. Shaanan also coauthored the later deoxyhemoglobin study with G. Fermi, Max Perutz and R. Fourme.^[ref] Comparing the two ligation states requires consistent geometric definitions; distances from different reference planes are different observables.

An original plane-fitting example makes that distinction concrete. A point at coordinate $z=0.30$ angstrom is 0.30 angstrom from the plane $z=0$, but only 0.10 angstrom from the parallel plane $z=0.20$ angstrom. The atom has not moved. Changing the atoms used to define a fitted plane can change a reported displacement.

For a unit normal $\mathbf{n}$ and point $\mathbf{p}$ on a reference plane, signed distance from position $\mathbf{r}$ isReversing the normal reverses the sign; translating both the model and its plane by the same vector leaves $d$ unchanged. These are geometric checks for interpreting a structural comparison, not additional measurements from the paper.

The value of the structural work is therefore more specific than an image of a protein: it turns questions about oxygen-binding geometry into quantities with stated reference conventions and experimental support. The published initials are retained rather than assuming a full identity from a similarly named crystallographer.

Chi Irg Yu is credited in the primary publisher byline as a coauthor, with Ruth E. Benesch and Reinhold Benesch, of the 1969 study of hemoglobin oxygenation in the presence of 2,3-Bisphosphoglycerate. The paper concerns how temperature, pH, ionic strength and hemoglobin concentration affect the oxygenation problem. The full spelling here follows that source; no additional career dates, appointments or identities are inferred from abbreviated citations.^[ref]

The scientific question separates oxygen affinity from the amount of oxygen carried. An equilibrium oxygenation curve describes oxygen saturation as a function of oxygen partial pressure under fixed conditions. The number of available binding sites additionally depends on how much hemoglobin is present. Equal saturation does not imply equal total bound oxygen.

For an original stoichiometric example, take a preparation containing $4\mu \mathrm{M}$ hemoglobin tetramers, each with four available oxygen-binding sites. Its site concentration is $16\mu \mathrm{M}$. At saturation $Y=0.75$, the concentration of bound oxygen molecules isA preparation with $6\mu \mathrm{M}$ tetramers at the same saturation instead contains $18\mu \mathrm{M}$ bound oxygen. These are constructed counts, not data from the 1969 paper. They show why protein concentration is a separate experimental variable from the fraction of occupied sites.

Regulator binding introduces another coupled equilibrium. 2,3-Bisphosphoglycerate preferentially binds deoxyhemoglobin, so a specified added amount of regulator need not equal its free concentration after protein binding. A comparison that changes protein concentration may change both available oxygen-binding capacity and regulator partitioning. The binding calculation in Ruth E. Benesch illustrates this free-versus-total distinction; the thermodynamic cycle in Reinhold Benesch explains reciprocal ligand coupling.

A controlled comparison therefore specifies protein amount, regulator amount, oxygen partial pressure, pH, temperature and solution composition, then identifies which readout was measured. Changing several of these together cannot isolate every individual influence from one saturation value. Yu's contribution is documented as part of the paper's coauthorship; that byline does not establish a separate allocation of particular experimental tasks.

Co-oximetry determines hemoglobin composition using optical measurements at multiple wavelengths. In a laboratory blood analyzer, it can distinguish oxyhemoglobin, deoxyhemoglobin, carboxyhemoglobin and methemoglobin rather than infer all hemoglobin behavior from a single oxygen-related number. A manufacturer description explicitly identifies direct optical spectrophotometry as the measurement method for its analyzer's co-oximetry parameters.^[ref]

An idealized mixture model makes the separating information explicit:where $A_j$ is measured absorbance, $\ell$ the path length, $c_i$ a species concentration, ${\epsilon }_i$ its molar absorption coefficient and $b_j$ a background term. Estimating four unconstrained concentrations requires sufficient independent spectral observations and known response coefficients; merely having four wavelength labels does not guarantee independence. An isosbestic point shared by two species supplies information about their combined amount but cannot by itself separate their proportions.

The denominator of a reported fraction matters. In a simplified four-form example, stipulate $90\%$ oxyhemoglobin, $5\%$ deoxyhemoglobin, $4\%$ carboxyhemoglobin and $1\%$ methemoglobin, all expressed on the same total-hemoglobin basis. Fractional oxyhemoglobin is $0.90$, but the functional oxygen saturation isThese differ because the second denominator excludes the other two forms. The manufacturer's parameter description distinguishes these definitions.^[ref] The chosen fractions are an explanatory example, not clinical thresholds.

A blood-sample optical assay and a noninvasive pulsatile optical measurement use different observation models. Their output labels and denominators must be established from the specific method, rather than inferred from the common word oximetry. Likewise, oxygen partial pressure describes dissolved oxygen equilibrium and is not itself a measurement of all hemoglobin fractions.

An instrument test can compare reference mixtures with independently established composition, record full spectral residuals and vary a suspected interferent. Agreement of one derived saturation number alone does not validate every inferred species concentration. Background, spectral overlap and sample handling belong in the measurement model and its uncertainty.

Deoxyhemoglobin is the unoxygenated form of hemoglobin whose available haem sites can reversibly bind oxygen. Releasing oxygen produces a binding-state change, rather than the ferric iron state defining methemoglobin. Carboxyhemoglobin differs again because a competing carbon monoxide ligand occupies a binding site. These distinctions matter when interpreting the components of an optical measurement.

In the instrument convention for functional oxygen saturation, HHb denotes the unoxygenated, oxygen-capable component. Its concentration appears with oxyhemoglobin in the denominator:The HHb label is not an instruction to treat deoxygenation as addition of a hydrogen molecule. Functional saturation also uses a different denominator from fractional oxyhemoglobin referenced to total hemoglobin.^[ref]

An original independent-site model illustrates a further counting distinction. Let each of four sites have oxygen-occupancy probability $\theta$, independently. The probability that a tetramer has exactly $m$ occupied sites isAt $\theta =1/2$, half the sites are empty on average, while only $P_0=1/16$ of tetramers have all four sites empty. A haem-equivalent unoxygenated fraction therefore need not equal the fraction of wholly unliganded tetramers. Real hemoglobin binding is cooperative, so independence here is a stated teaching assumption rather than a physiological model.

Deoxyhemoglobin and oxyhemoglobin have distinguishable absorption spectra. A primary study measured the absorptivities of these and other human hemoglobin derivatives across 450–1000 nm, including fetal/adult differences relevant to multicomponent analysis.^[ref] A controlled oxygenation comparison can therefore follow changing spectral contributions without inferring oxygen amount from apparent colour alone. The measured path length, concentrations and calibrated component spectra remain necessary inputs.

Fetal hemoglobin, commonly HbF, is a hemoglobin form built from two alpha-globin and two gamma-globin subunits, written ${\alpha }_2{\gamma }_2$. The major adult form, hemoglobin A, instead has the ${\alpha }_2{\beta }_2$ combination. Fetal identity concerns subunit composition; oxyhemoglobin and deoxyhemoglobin concern oxygen occupancy. The same fetal molecule can change its oxygenation state without becoming adult hemoglobin.

Primary structural evidence is available in the human fetal deoxyhemoglobin crystal structure 1FDH. Its experimental record identifies an alpha/gamma tetramer determined by X-ray diffraction at $2.50\mathring{\mathrm{A}}$ resolution.^[ref] The related paper connects structural differences with weaker interaction with 2,3-Bisphosphoglycerate, an effector relevant to oxygen-binding behavior.^[ref] A structure constrains a mechanism, while an affinity curve requires a functional measurement under specified conditions.

An original Hill equation model illustrates what higher oxygen affinity means. Let fractional occupancy at oxygen partial pressure $p$ beWith the same stipulated $n=2$, compare midpoints $P_{50}=20$ and 30 in arbitrary pressure units. At $p=25$, their occupancies areThe lower midpoint gives greater occupancy at the same pressure. It does not imply that the protein carries more than one oxygen molecule per available haem site. These midpoints and the exponent are teaching parameters, not measured fetal/adult reference values.

Subunit identity also matters analytically. A primary 1991 experiment measured fetal and adult hemoglobin derivative spectra over 450–1000 nm and found differences relevant to multicomponent analysis.^[ref] An optical model that distinguishes oxygenation states should therefore also justify which protein-form spectra it uses. Oxygen occupancy, subunit composition and total protein concentration are different quantities.

Fractional oxyhemoglobin is the oxyhemoglobin concentration divided by the concentration of all measured hemoglobin species in the same blood sample. With $H_O,H_D,H_C,H_M$ denoting oxyhemoglobin, deoxyhemoglobin, carboxyhemoglobin and methemoglobin concentrations, respectively,Additional measured hemoglobin species belong in the denominator when present. Functional oxygen saturation instead uses $H_O/(H_O+H_D)$. The distinction is the denominator, not whether the result is written as a fraction or a percentage.^[ref]

For a constructed mixture with concentrations proportional to $85,5,10,0$, respectively, fractional oxyhemoglobin is $85\%$, while functional oxygen saturation is $85/90\approx 94.4\%$. The second number excludes the carboxyhemoglobin from its denominator; it has not created additional oxygen-carrying oxyhemoglobin.

This distinction matters when converting hemoglobin measurements into arterial oxygen content. If $H$ is total hemoglobin concentration and $\beta$ is a stipulated oxygen-binding capacity per unit hemoglobin mass, the bound-oxygen term is $\beta H{F}_{{\mathrm{O}}_2\mathrm{Hb}}$. Choosing $H=15$ g/dL and $\beta =1.34$ mL/g in the example gives $17.085$ mL of bound oxygen per dL of blood. Substituting $85/90$ instead would give about $18.98$ mL/dL. This calculation isolates the denominator error; dissolved oxygen is a separate contribution. A measurement of oxygen saturation alone therefore does not determine total blood oxygen content.

Functional oxygen saturation is the fraction of the sum of oxyhemoglobin and deoxyhemoglobin that is present as oxyhemoglobin:Here $H_O$ and $H_D$ are the corresponding concentrations in the same blood sample. Carboxyhemoglobin and methemoglobin are excluded from this denominator. Fractional oxyhemoglobin instead divides by the total concentration of measured hemoglobin species.^[ref]

A constructed example shows what the exclusion does. If a sample contains 90 concentration units of oxyhemoglobin, 10 of deoxyhemoglobin and 25 of carboxyhemoglobin, its functional oxygen saturation is $90/(90+10)=0.90$. Its fractional oxyhemoglobin is $90/125=0.72$. Both values describe the same mixture, with different reference populations.

If $d$ denotes the fraction of total hemoglobin excluded from the functional denominator, thenThus knowing only $s_{{\mathrm{O}}_2}$ does not determine the oxygenated fraction of total hemoglobin unless $d$ is also known or negligible. In the example, $d=25/125=0.20$ and $0.90(1-0.20)=0.72$.

The distinction has an experimental consequence for co-oximetry. Optical analysis must distinguish the absorbing hemoglobin derivatives before calculating the desired ratio; changing the denominator of the displayed result does not change the blood sample. Total oxygen content additionally requires hemoglobin concentration and the dissolved oxygen contribution. Hemoglobin-concentration and saturation separation therefore remains necessary even when functional oxygen saturation has been measured accurately.

Gamma-globin is the globin-chain class that pairs with alpha-globin in fetal hemoglobin, whose standard composition is ${\alpha }_2{\gamma }_2$. In humans, the HBG1 and HBG2 genes encode closely related gamma-chain products.^[ref] The NCBI annotations distinguish A-gamma from G-gamma by alanine versus glycine at residue 136; gamma is therefore not necessarily a single sequence label.

The human fetal deoxyhemoglobin structure 1FDH provides a molecular example, identifying alpha and gamma entities within the tetramer.^[ref] The gamma chain occupies a protein-subunit role; it is not a gamma photon or a description of the molecule's oxygenation state.

An original amount calculation makes the subunit distinction useful. Suppose an assay quantifies 120 pmol total gamma chains, with 90 pmol of one sequence form and 30 pmol of the other. Their chain fractions are 0.75 and 0.25. If every measured gamma chain belongs to fetal tetramers containing exactly two gamma chains, total fetal hemoglobin isIf 12 pmol of that measured gamma pool is instead free or belongs to other material, the same tetramer interpretation gives $(120-12)/2=54$ pmol. A total chain assay does not by itself prove where every chain was assembled.

A separate sequence-selective assay can establish which gamma forms are present, while a composition or functional measurement tests the assembled hemoglobin. Changes in HBG1 or HBG2 expression are questions about the producing system; changes in oxyhemoglobin versus deoxyhemoglobin are questions about oxygen binding. Keeping those levels separate prevents a molecular identity result from being mistaken for a complete physiological measurement.

G. Fermi is the first author of the 1984 study refining human deoxyhemoglobin at $1.74\mathring{\mathrm{A}}$ resolution, and is named with Max Perutz as a depositor of its primary structure record, 4HHB.^[ref] The published initial-only identity is retained.

The model allowed the investigators to examine local geometry around iron in the oxygen-binding groups of hemoglobin. Their analysis also tested whether conclusions about that geometry persisted when selected model restraints were removed.^[ref] Such a comparison asks how strongly the observations constrain a feature independently of assumptions imposed during fitting.

An original one-parameter calculation illustrates this issue without recreating the historical refinement. Suppose a scalar coordinate $x$ is constrained by an observed value $y$ with uncertainty $\sigma$, and by a preferred value $x_0$ with strength $\lambda$. MinimizeFor $y=0.40$, $\sigma =0.05$, $x_0=0$ and $\lambda =400$ in compatible units, $\hat{x}=0.20$. Removing the restraint gives $\hat{x}=0.40$. A fitted value can therefore depend on both observations and a modeling choice. This toy weighted least squares problem is not the algorithm used for 4HHB.

Agreement with data should consequently be examined together with restraint sensitivity and independent physical evidence. A precise-looking coordinate is not established merely by printing many decimal places. Fermi's documented work exemplifies using X-ray crystallography to make a molecular arrangement quantitatively testable.

J. A. Frier coauthored the 1977 study of human fetal deoxyhemoglobin with Max Perutz. The primary structure record 1FDH reports a human alpha/gamma tetramer examined by X-ray diffraction at $2.50\mathring{\mathrm{A}}$ resolution.^[ref] This is a verified structural-biology contribution; the published initials are retained without inferring an expanded identity from a deposition-name variant.

Comparing fetal and adult hemoglobin structures tests how changes in subunit composition alter local interactions. The paper's indexed abstract discusses differences at the binding region for 2,3-Bisphosphoglycerate.^[ref] Such a comparison can suggest why an effector binds differently. It does not make a static crystal structure a direct measurement of all physiological response rates or affinities.

An original coordinate example distinguishes spatial resolution from uncertainty in a derived distance. Suppose two modeled positions along one axis differ by $3.0\mathring{\mathrm{A}}$, with independent standard uncertainties $0.2\mathring{\mathrm{A}}$ each. The uncertainty of their signed separation isIf the coordinate errors have covariance $c$, the variance becomes $0.2^2+0.2^2-2c$. Shared model errors can therefore change the uncertainty of a relative separation. These are illustrative assumptions, not coordinate uncertainties reported for 1FDH.

A quoted diffraction resolution alone should not be substituted for either number in this example. It describes the experimental detail available to the model, while coordinate uncertainty also depends on data, occupancy, disorder and refinement. Frier and Perutz's structural result is valuable because it offers a molecular arrangement against which those broader mechanistic questions can be tested.

Max Perutz, fully Max Ferdinand Perutz, investigated protein structure through X-ray diffraction. The Nobel nomination archive explicitly pairs his full name with the initials M. F. Perutz and records his 1962 Chemistry prize.^[ref] His structural research connected the organization of protein atoms with the behavior of oxygen-binding hemoglobin.

With J. A. Frier, Perutz coauthored the structure of human fetal deoxyhemoglobin. The associated primary record, 1FDH, identifies alpha and gamma chains and a diffraction resolution of $2.50\mathring{\mathrm{A}}$.^[ref] The study relates structural differences to interaction with 2,3-Bisphosphoglycerate. A structural explanation is strongest when its proposed interaction can also be tested through functional measurements.

An original diffraction example shows why obtaining a molecular structure is not equivalent to photographing atoms directly. In a reduced model, a complex scattering amplitude iswhere $x_j$ are positions and $f_j$ scattering strengths. Measured intensity is proportional to $|F(q){|}^2$. Translating every atom by $x_0$ multiplies $F$ by $e^{iq{x}_0}$ without changing that intensity. Intensities therefore do not by themselves fix every phase or coordinate convention. Recovering an electron density model requires appropriate phase information and structural constraints, connecting the measurement with the phase problem.

The fetal structure also illustrates a separate limitation: identifying a deoxygenated conformation does not directly measure the entire oxygen-binding curve. Structural comparisons, ligand-binding experiments and quantitative analysis supply complementary evidence. Perutz's contribution lies in connecting those molecular questions with experimentally determined three-dimensional organization.

Methemoglobin is a hemoglobin derivative with oxidized ferric iron at a haem site. The ferric site cannot perform the usual reversible oxygen binding of an available ferrous site. The distinction is one of oxidation state, not merely whether an oxygen molecule currently occupies the site.^[ref] An adult hemoglobin tetramer contains four haem sites, so site occupancy and the state of the whole tetramer must not be silently conflated.

Deoxyhemoglobin retains the capacity to bind oxygen at its available sites. A ferric site in methemoglobin instead requires chemical reduction to restore the corresponding ferrous state. Formation of oxyhemoglobin is therefore different from accumulating ferric haem. Changes in the surrounding protein also influence the properties of remaining sites; a site-count calculation alone is not a complete cooperative-binding model.

For an original capacity calculation, suppose a sample contains 100 micromoles of haem sites, with 20 micromoles ferric and the other 80 capable of reversible oxygen binding. The latter can bind at most 80 micromoles of oxygen in a one-molecule-per-site model. If 60 micromoles are oxygenated, the oxygenated fraction of all haem sites is $60/100=0.60$, while the occupied fraction of the stipulated capable sites is $60/80=0.75$. A denominator change produces different percentages without changing the sample.

Experimentally, spectrophotometry distinguishes derivatives through calibrated absorption spectra. A 1991 primary study measured human fetal and adult oxyhemoglobin, unoxygenated hemoglobin, carboxyhemoglobin and methemoglobin spectra over 450–1000 nm.^[ref] The relevant inverse problem has the formwhere path length $\ell$, derivative concentrations $c_j$ and their calibrated absorption coefficients determine the modeled absorbance. Co-oximetry uses multiple spectral measurements to estimate such derivative fractions. A single colour observation cannot generally separate several unknown components.

Oxyhemoglobin is oxygen-bound hemoglobin. Binding is reversible: an available haem site can acquire or release an oxygen molecule as conditions change. A fully occupied adult hemoglobin tetramer carries four oxygen molecules, one per haem site.^[ref] Oxygenation describes ligand occupancy and should not be confused with the ferric haem state defining methemoglobin.

A quantitative description must specify its denominator. The manufacturer's functional oxygen saturation iswhere HHb denotes unoxygenated, oxygen-capable hemoglobin. A fractional oxyhemoglobin quantity instead divides by total hemoglobin, including specified non-oxygen-carrying derivatives.^[ref] The concentrations must use a consistent haem-equivalent convention.

For an original four-component example, suppose those equivalent concentrations are 80 units oxyhemoglobin, 5 units deoxyhemoglobin, 10 units carboxyhemoglobin and 5 units methemoglobin. Then functional saturation is $80/85\approx 94.1\%$, whereas the oxyhemoglobin fraction of the full 100-unit total is $80\%$. These describe the same hypothetical mixture with different denominators. Neither percentage alone states the total oxygen amount in a blood volume.

A separate amount calculation assumes 2 micromoles of tetramers, all with four functional sites, at mean occupancy $0.75$. Bound oxygen is thenAny oxygen dissolved outside hemoglobin is an additional pool. Concentration, binding fraction and gas partial pressure are related through a physical model, rather than being interchangeable measurements.

Primary spectral work measured oxyhemoglobin alongside other derivatives, providing coefficient data for distinguishing their contributions to absorbance.^[ref] This connects molecular oxygenation with a measurable optical signal while retaining the distinction between one derivative and the whole sample.

Reinhold Benesch was a biochemist who investigated hemoglobin function in collaboration with Ruth E. Benesch. Their 1969 account of intracellular organic phosphates explained a mechanism by which 2,3-Bisphosphoglycerate changes oxygen affinity: the regulator binds preferentially to deoxyhemoglobin, making oxygen release more favourable at a specified oxygen partial pressure. This identifies a chemical regulator of oxygen transport, rather than treating hemoglobin affinity as an immutable property of the isolated protein.^[ref]

The discovery is an example of allostery: ligand binding at one part of a molecular system affects binding elsewhere. A short equilibrium argument shows why the effect is reciprocal. Consider an original four-state model with one oxygen ligand $O$ and one regulator $B$, allowing states $H$, $HO$, $HB$ and $HOB$. Define dissociation constantsMultiplying around the two possible binding paths givesThus, if regulator binding makes oxygen ten times harder to bind in this model, $K_{O\mid B}/K_O=10$, oxygen binding must likewise increase the regulator's dissociation constant tenfold. An equilibrium coupling cannot act in only one direction. The four-state construction is an illustrative reduction, not a claim that the four oxygen-binding subunits of real hemoglobin behave as one physical site.

This reasoning motivates a controlled measurement: compare oxygen-equilibrium curves for matched hemoglobin preparations with different regulator concentrations, while controlling pH, temperature and solution composition. Measuring regulator binding as well tests the reciprocal side of the proposed mechanism. His coauthored 1969 paper with Ruth E. Benesch and Chi Irg Yu explicitly examined how several of these conditions enter the oxygenation problem.^[ref]

The scientific contribution is collective in these sources. Their joint paper does not establish a separate personal allocation of the chemical preparation, measurements and interpretation. The photograph below is the institutionally identified joint image, credited to Columbia University's Department of Biochemistry.^[ref]

R. Fourme coauthored the 1984 high-resolution structure of human deoxyhemoglobin with G. Fermi, Max Perutz and B. Shaanan. The primary record describes X-ray diffraction collected on film at room temperature using synchrotron radiation, followed by refinement at $1.74\mathring{\mathrm{A}}$ resolution.^[ref] This establishes a contribution to experimental structural biology; the byline alone does not assign each instrument or calculation to one coauthor.

The physical chain is illuminating: a crystal scatters the incident radiation, a detector records diffraction intensity, and a model connects the measurements with an electron density distribution. Improving incident flux can help collect weak reflections, but flux and spatial resolution remain different quantities.

For an original counting example, suppose an ideal detector records 400 independent photons in one reflection and background is negligible. A Poisson distribution then gives standard uncertainty $\sqrt{400}=20$ counts, or 5% relative uncertainty. Four times as many recorded photons gives 1,600 counts and $40/1600=2.5\%$ relative uncertainty. The square-root improvement describes the chosen counting model; it is not a measured uncertainty for the historical film detector.

Increasing exposure also need not preserve the specimen unchanged. A comparison should keep track of radiation-induced changes, detector response and background rather than assuming that every additional count is interchangeable. Those experimental controls complement the molecular constraints used in X-ray crystallography. Fourme's verified coauthorship connects the biological question to the apparatus needed to obtain its structural evidence.

Ruth E. Benesch was a biochemist whose work with Reinhold Benesch investigated hemoglobin and its interaction with small-molecule regulators. Their jointly authored 1969 account connected 2,3-Bisphosphoglycerate in red blood cells with lower oxygen affinity through preferential binding to deoxyhemoglobin. The published full byline uses Ruth E. Benesch; the middle initial is retained here.^[ref]

She was first author of a separate 1969 study of hemoglobin oxygenation in the presence of the same metabolite, with Reinhold Benesch and Chi Irg Yu. Its stated experimental variables were temperature, pH, ionic strength and hemoglobin concentration. Those variables matter because a ligand's effect is a property of the complete chemical equilibrium under specified conditions, not just the name of the ligand. The shared byline supports a collaborative contribution; it does not identify who performed every apparatus task.^[ref]

An original binding calculation illustrates why protein concentration belongs in such a comparison. In a deliberately simplified one-site model, let $H_T$ be the total concentration of binding sites, $B$ the free concentration of 2,3-Bisphosphoglycerate, and $K_d$ its dissociation constant. The bound concentration isAt $H_T=1.0\mathrm{mM}$ and $B=K_d=0.10\mathrm{mM}$, half the sites are occupied: $[HB]=0.50\mathrm{mM}$. The total ligand concentration is $B_T=0.60\mathrm{mM}$, not $0.10\mathrm{mM}$. Substituting total concentration for free concentration would predict a different occupancy. These are stipulated numbers, not measured binding constants from her paper.

The biochemical insight extends beyond the small molecule: oxygenation and regulator binding are coupled properties of a protein. Their 1969 joint account describes one bound phosphate-metabolite molecule per hemoglobin tetramer, rather than one for every oxygen-binding subunit. This distinguishes regulatory stoichiometry from oxygen-carrying capacity.^[ref]

The historical photograph below is explicitly identified by the Science History Institute and credited to Columbia University's Department of Biochemistry.^[ref]

W. G. Zijlstra is the first author of a 1991 study with A. Buursma and W. P. Meeuwsen-van der Roest measuring visible and near-infrared reference spectra of human hemoglobin derivatives. The authors reported that small fetal/adult differences in molar absorption coefficient mattered for multicomponent analysis.^[ref] The work connects experimental optical measurements to the quantitative interpretation of blood samples.

The central measurement distinction is between a chemical species and a total signal. Oxyhemoglobin, deoxyhemoglobin, carboxyhemoglobin and methemoglobin can all contribute to measured absorbance, while functional oxygen saturation uses only the first two in its denominator. A fitted total optical signal therefore needs chemical interpretation before it becomes an oxygen-transport quantity.

An original synthetic example makes that separation concrete. If inferred concentrations are $H_O=8$, $H_D=2$ and $H_C=2$ with the remaining species absent, then functional oxygen saturation is $8/(8+2)=0.8$, whereas fractional oxyhemoglobin is $8/(8+2+2)=2/3$. Multiplying every concentration by two doubles the mixture's predicted absorbance at fixed path length under the Beer-Lambert law, but leaves both fractions unchanged.

Reference spectra thus help distinguish composition, concentration and denominator choice. This is the scientific role of the documented study; it should not be confused with directly measuring oxygen consumption, blood flow or cardiac output. Those quantities require additional observations and balance assumptions.

W. P. Meeuwsen-van der Roest coauthored a 1991 experimental study with W. G. Zijlstra and A. Buursma measuring the molar absorption coefficient of four derivatives of fetal hemoglobin and adult hemoglobin across 450–1000 nm. The work supplied spectral reference measurements relevant to separating oxyhemoglobin, deoxyhemoglobin, carboxyhemoglobin and methemoglobin by optical analysis.^[ref]

The scientific point is that similar-looking spectra need not be interchangeable reference data. In co-oximetry, a model based on the Beer-Lambert law combines reference spectra to infer component concentrations. A small reference mismatch can alter the inferred mixture even when the measured absorbance is precise.

An original two-component example explains the sensitivity. Suppose two synthetic readings satisfyThen $c_2=(a_2-a_1)/ϵ$. If $ϵ=0.01$, an error of $0.001$ in $a_2-a_1$ changes the inferred $c_2$ by $0.1$ in the model's concentration units. Near-similarity of reference columns can therefore amplify small errors. These invented coefficients illustrate the inverse problem; they are not the paper's measured hemoglobin spectra.

The documented contribution is to the joint experimental reference study. Its byline establishes coauthorship, while the spectra and their use in mixture analysis explain why the work matters beyond a list of publications.